“With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the top medications available for outpatient, office-based treatment, once initiated, are equally safe and effective in curtailing opioid use, relapse, treatment drop-out and overdose.
Researchers in the Departments of Psychiatry and Population Health at NYU School of Medicine, who led the study sponsored by the National Institute on Drug Abuse (NIDA) and published online November 14, 2017 in The Lancet, conclude that extended-release naltrexone (an opioid antagonist marketed as Vivitrol) demonstrated similar safety and clinical effectiveness to more commonly prescribed buprenorphine-naloxone (an opioid agonist marketed both generically and as Suboxone).” Read more at: https://medicalxpress.com/news/2017-11-opioid-treatment-drugs-similar-outcomes.html
Source: MedicalExpress.com – November 14, 2017
See related article: Senator Kamala Harris Wants Probe of ‘Miracle Drug’ Touted by Governor Ducey available at: http://www.phoenixnewtimes.com/news/kamala-harris-wants-probe-of-vivitrol-drug-touted-by-doug-ducey-9861981
See related article: Study Shows Two Addiction Medications Similar But Drop Out Rates High: Three Possible Remedies available at: https://www.forbes.com/sites/sallysatel/2017/11/27/study-shows-two-addiction-medications-similar-but-drop-out-rates-high-three-possible-remedies/#65b38dff3884